Navigation Links
AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting

e attained an overall 52% CBR which compares favorably with the activity of mTOR inhibitors; - Low dose perifosine (daily and weekly) achieved the same CBR as high dose, including four partial responses; - Toxicities were mainly gastrointestinal and/or fatigue. Low dose perifosine led to substantially less toxicity and decreased early withdrawal from therapy compared to high dose perifosine.

A multi-center Phase 2 trial of low-dose perifosine in sarcomas that generally do not respond to chemotherapy, including chondrosarcoma and myxoid chondrosarcoma, is currently underway through the Sarcoma Alliance for Research through Collaboration (SARC) network.

About Perifosine (KRX-0401)

Perifosine is a novel, first-in-class, oral anti-cancer agent that modulates several key signal transduction pathways, including Akt, MAPK, and JNK that have been shown to be critical for the survival of cancer cells. Perifosine has demonstrated single agent anti-tumor activity in Phase 1 and Phase 2 studies and is currently being studied as a single agent and in combination with several forms of anti-cancer treatments for various forms of cancer. Perifosine (KRX-0401) is licensed to Keryx Biopharmaceuticals in the United States, Canada and Mexico.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aeternazentaris.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes", "anticip
'"/>




Page: 1 2 3 4

Related medicine technology :

1. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
2. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
3. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. GenoLogics Announces Bioinformatics Partnership with Illumina
9. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
10. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
11. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
Post Your Comments:
(Date:7/23/2014)... , July 23, 2014 UBM Medica ... – a new online community and information resource for ... manage and treat their patients with neurological disorders ... with an aging population, necessitates greater access to dedicated ...  Key statistics on neurological conditions include: , ...
(Date:7/23/2014)... , July 23, 2014 Research and ... Electrocardiograph (ECG) Market by Product, End-user & by Lead ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... segmented into three major segments, namely, holter monitor, resting, ... was valued at $3,683 million in 2013 and is ...
(Date:7/23/2014)... /PRNewswire-iReach/ -- The Centers for Medicare & Medicaid Services ... Improvement Organization (QIN-QIO) contract to a partnership led by ... August 1, WVMI will launch Quality Insights Quality Innovation ... Pennsylvania , Delaware , ... Network will engage providers and the community in multiple, ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
(Date:7/23/2014)... Worth, FL (PRWEB) July 23, 2014 ... take place Aug. 10-16, Millennium Treatment Group is providing ... abuse has existed in society ever since man first ... wine. Substance abuse treatment has existed since shortly thereafter. ... recognizing a problem and then developing a way to ...
(Date:7/23/2014)... July 24, 2014) If past experience is anything ... are about to get a lot more recognition for ... on the books allowing NPs to provide primary care ... care and better relationships with physicians and administrators, compared ... from Columbia University School of Nursing, published in ...
(Date:7/23/2014)... a suspicious skin lesion is painful or itchy may ... be cancerous, according to a new study headed by ... at Temple University School of Medicine. , The study, ... 23, 2014, found that nearly 36. 9 percent of ... percent involve pain. Non-melanoma skin cancers specifically, basal ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Home ... in-home care for seniors, is proud to announce the ... featuring experts in a wide range of health and ... social worker and award-winning author Nancy Kriseman, and will ... ways to prevent burnout by becoming more self-aware. In ...
(Date:7/23/2014)... July 23, 2014 (HealthDay News) -- Regularly checking the ... stroke, researchers report. "Screening pulse is the method ... over age 65 who have never had a stroke. ... noninvasive and easy way to identify people who might ... said study author Dr. Bernd Kallmunzer, of Erlangen University ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:New York law offers nurses more recognition, responsibility 2Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 2Health News:Home Care Assistance Calgary to Host Public Webinar on the Topic of Caregiver Mindfulness 3Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2
... Supplier of the Year by UHC and Novation for ... Consortium (UHC) and Novation, the healthcare industry,s leading contracting ... Incorporated (NYSE: OMX ), a ... 2009 recipient of UHC Service Excellence Supplier Award most ...
... Joseph,s Hospital in Tampa Named One of the ... St. Joseph,s Hospital, a member of BayCare ... the leading hospitals in the United States, in a study ... May/June issue of AARP The Magazine. Consumers, Checkbook is ...
... UC San Diego School of Medicine and the Moores UCSD ... system cell thought to be part of the first line ... spread. They have found that when these cells, known as ... cancer is more likely to spread to the lungs. ...
... the medical literature by a panel of experts at ... held this month in Phoenix concluded that there is ... greatest number of transfusions currently being given to patients. ... between red blood cell transfusions and higher rates of ...
... Abstract #5637DENVER, April 22 Scientists from ... Detroit presented data today at the American ... 2009 that signifies exciting research advancements in ... of breast cancer.(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )Researchers ...
... and Wellness and Reducing Common and Costly Chronic Disease ... to Senate and House LeadershipWASHINGTON, April 22 More ... Disease (PFCD) - an organization representing some of the ... on leaders in Congress to encourage updates in the ...
Cached Medicine News:Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 3Health News:Baycare Health System Hospital Earns National Recognition 2Health News:Instead of fighting breast cancer, immune cell promotes its spread 2Health News:Blood transfusions and outcomes 2Health News:Blood transfusions and outcomes 3Health News:Blood transfusions and outcomes 4Health News:Karmanos Cancer Institute Researchers Provide New Hope for Breast Cancer Treatment 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 2Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 3Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 4Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 5Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 6Health News:Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: